These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11461999)

  • 1. Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors.
    Wang D; de la Fuente C; Deng L; Wang L; Zilberman I; Eadie C; Healey M; Stein D; Denny T; Harrison LE; Meijer L; Kashanchi F
    J Virol; 2001 Aug; 75(16):7266-79. PubMed ID: 11461999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological cyclin-dependent kinase inhibitors inhibit replication of wild-type and drug-resistant strains of herpes simplex virus and human immunodeficiency virus type 1 by targeting cellular, not viral, proteins.
    Schang LM; Bantly A; Knockaert M; Shaheen F; Meijer L; Malim MH; Gray NS; Schaffer PA
    J Virol; 2002 Aug; 76(15):7874-82. PubMed ID: 12097601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription.
    Schang LM; Phillips J; Schaffer PA
    J Virol; 1998 Jul; 72(7):5626-37. PubMed ID: 9621021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roscovitine, a specific inhibitor of cellular cyclin-dependent kinases, inhibits herpes simplex virus DNA synthesis in the presence of viral early proteins.
    Schang LM; Rosenberg A; Schaffer PA
    J Virol; 2000 Mar; 74(5):2107-20. PubMed ID: 10666240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases.
    Schang LM; Rosenberg A; Schaffer PA
    J Virol; 1999 Mar; 73(3):2161-72. PubMed ID: 9971799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibitor of cyclin-dependent kinases, olomoucine II, exhibits potent antiviral properties.
    Holcakova J; Tomasec P; Bugert JJ; Wang EC; Wilkinson GW; Hrstka R; Krystof V; Strnad M; Vojtesek B
    Antivir Chem Chemother; 2010 Jan; 20(3):133-42. PubMed ID: 20054100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CDK inhibitor p21Cip1/WAF1 is induced by FcgammaR activation and restricts the replication of human immunodeficiency virus type 1 and related primate lentiviruses in human macrophages.
    Bergamaschi A; David A; Le Rouzic E; Nisole S; Barré-Sinoussi F; Pancino G
    J Virol; 2009 Dec; 83(23):12253-65. PubMed ID: 19759136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kainate receptor-mediated apoptosis in primary cultures of cerebellar granule cells is attenuated by mitogen-activated protein and cyclin-dependent kinase inhibitors.
    Giardina SF; Beart PM
    Br J Pharmacol; 2002 Apr; 135(7):1733-42. PubMed ID: 11934814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cyclin-dependent kinase family in the social amoebozoan Dictyostelium discoideum.
    Huber RJ
    Cell Mol Life Sci; 2014 Feb; 71(4):629-39. PubMed ID: 23974243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel R-roscovitine NO-donor hybrid compounds as potential pro-resolution of inflammation agents.
    Montanaro G; Bertinaria M; Rolando B; Fruttero R; Lucas CD; Dorward DA; Rossi AG; Megson IL; Gasco A
    Bioorg Med Chem; 2013 Apr; 21(7):2107-16. PubMed ID: 23394865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemically induced phenotype plasticity in the unicellular zygnematophyte, Penium margaritaceum.
    LoRicco JG; Bagdan K; Sgambettera G; Malone S; Tomasi T; Lu I; Domozych DS
    Protoplasma; 2024 Jul; ():. PubMed ID: 38967680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDK2 regulates HIV-1 transcription by phosphorylation of CDK9 on serine 90.
    Breuer D; Kotelkin A; Ammosova T; Kumari N; Ivanov A; Ilatovskiy AV; Beullens M; Roane PR; Bollen M; Petukhov MG; Kashanchi F; Nekhai S
    Retrovirology; 2012 Nov; 9():94. PubMed ID: 23140174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule inhibitors of transcriptional cyclin-dependent kinases impose HIV-1 latency, presenting "block and lock" treatment strategies.
    Horvath RM; Brumme ZL; Sadowski I
    Antimicrob Agents Chemother; 2024 Mar; 68(3):e0107223. PubMed ID: 38319085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin-dependent kinase inhibitor fadraciclib (CYC065) depletes anti-apoptotic protein and synergizes with venetoclax in primary chronic lymphocytic leukemia cells.
    Chen R; Chen Y; Xiong P; Zheleva D; Blake D; Keating MJ; Wierda WG; Plunkett W
    Leukemia; 2022 Jun; 36(6):1596-1608. PubMed ID: 35383271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of CDKN1A/p21 in HIV-1 controllers is correlated with upregulation of ZC3H12A/MCPIP1.
    de Azevedo SSD; Ribeiro-Alves M; Côrtes FH; Delatorre E; Spangenberg L; Naya H; Seito LN; Hoagland B; Grinsztejn B; Veloso VG; Morgado MG; Souza TML; Bello G
    Retrovirology; 2020 Jul; 17(1):18. PubMed ID: 32615986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural Products Mediated Targeting of Virally Infected Cancer.
    Fatima I; Kanwal S; Mahmood T
    Dose Response; 2019; 17(1):1559325818813227. PubMed ID: 30670935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein Phosphatase-1 -targeted Small Molecules, Iron Chelators and Curcumin Analogs as HIV-1 Antivirals.
    Lin X; Ammosova T; Kumari N; Nekhai S
    Curr Pharm Des; 2017; 23(28):4122-4132. PubMed ID: 28677499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction.
    Pleet ML; Mathiesen A; DeMarino C; Akpamagbo YA; Barclay RA; Schwab A; Iordanskiy S; Sampey GC; Lepene B; Nekhai S; Aman MJ; Kashanchi F
    Front Microbiol; 2016; 7():1765. PubMed ID: 27872619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphoproteomics to Characterize Host Response During Influenza A Virus Infection of Human Macrophages.
    Söderholm S; Kainov DE; Öhman T; Denisova OV; Schepens B; Kulesskiy E; Imanishi SY; Corthals G; Hintsanen P; Aittokallio T; Saelens X; Matikainen S; Nyman TA
    Mol Cell Proteomics; 2016 Oct; 15(10):3203-3219. PubMed ID: 27486199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular dynamics simulation and experimental verification of the interaction between cyclin T1 and HIV-1 Tat proteins.
    Asamitsu K; Hirokawa T; Hibi Y; Okamoto T
    PLoS One; 2015; 10(3):e0119451. PubMed ID: 25781978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.